GPR17 signaling activation by CHBC agonist induced cell death via modulation of MAPK pathway in glioblastoma
- 10 January 2022
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 291, 120307
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensationTrends in Biochemical Sciences, 2011
- The ERK Cascade: Distinct Functions within Various Subcellular OrganellesGenes & Cancer, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The Recently Identified P2Y-Like Receptor GPR17 Is a Sensor of Brain Damage and a New Target for Brain RepairPLOS ONE, 2008
- Executioner caspase-3 and caspase-7 are functionally distinct proteasesProceedings of the National Academy of Sciences, 2008
- Glycogen Synthase Kinase-3 Inhibition Induces Glioma Cell Death through c-MYC, Nuclear Factor-κB, and Glucose RegulationCancer Research, 2008
- Mitogenic signaling pathways induced by G protein‐coupled receptorsJournal of Cellular Physiology, 2007
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- Mitogen-activated protein kinases in apoptosis regulationOncogene, 2004
- The permeability transition pore signals apoptosis by directing Bax translocation and multimerizationThe FASEB Journal, 2002